Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 261

Results For "healthcare"

2662 News Found

TAKE divests stake in Navitas Life Sciences to HIG
Biotech | August 08, 2021

TAKE divests stake in Navitas Life Sciences to HIG

The transaction is expected to close in the Q4FY22


Aartas launches co-working space for doctors under Clinishare
Healthcare | August 04, 2021

Aartas launches co-working space for doctors under Clinishare

Startup receives US $ 5 million in first round of funding


Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Healthcare | August 03, 2021

Nureca Ltd PAT at Rs 36.19 crore in Q1FY22

Nureca Ltd has reported financial results for the period ended June 30, 2021.


Abbott's Freestyle Libre 2 Ios App Cleared In U.S
Drug Approval | August 03, 2021

Abbott's Freestyle Libre 2 Ios App Cleared In U.S

FreeStyle Libre 2 iOS app is the only sensor-based glucose monitoring app that allows users to check their glucose with a compatible iPhone every minute with optional real-time glucose alarms


Meddo acquires Doxper in a cash and stock deal
Healthcare | August 03, 2021

Meddo acquires Doxper in a cash and stock deal

This deal makes Meddo, one of the largest health-tech players in India


Clinical trials in the UK to study the efficacy of Ashwagandha on COVID 19 patients
Drug Approval | August 02, 2021

Clinical trials in the UK to study the efficacy of Ashwagandha on COVID 19 patients

Ayush Ministry will conduct the study along with the UK’s London School of Hygiene and Tropical Medicine


Hugely successful vaccination roll out made possible by India-UK partnership
Policy | July 28, 2021

Hugely successful vaccination roll out made possible by India-UK partnership

The contribution of Wockhardt at Wrexham is one of the best examples of the success and significant potential of India-UK partnerships in the healthcare sector


GlaxoSmithKline delivers 19% revenue growth for Q1 FY22
News | July 27, 2021

GlaxoSmithKline delivers 19% revenue growth for Q1 FY22

The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited


Syngene Q1 FY22 revenue grows 41%
News | July 21, 2021

Syngene Q1 FY22 revenue grows 41%

The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels


Merck invests €270 million in a new research center at Darmstadt
News | July 19, 2021

Merck invests €270 million in a new research center at Darmstadt

As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies